Search results

Skip to results

Type

Type

Last updated

Last updated

Guidance programme

Your search for Lenisurad returned no results
Showing 1 result for lesinurad

  1. Lesinurad for treating chronic hyperuricaemia in people with gout (TA506)

    We have withdrawn this guidance. Grünenthal has stopped marketing Lesinurad (Zurampic) for commercial reasons and its marketing authorisation has been withdrawn.

    Withdrawn guidance